Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/01/2012EP2481395A1 Sachet, effervescent tablet and dry syrup of otilonium
08/01/2012EP2481382A1 Nail correcting device and medical set for nail correction
08/01/2012EP2480669A2 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
08/01/2012EP2480668A2 Compositions and methods for silencing genes expressed in cancer
08/01/2012EP2480557A2 Process for the preparation of rapamycin derivatives
08/01/2012EP2480556A1 Heterocyclic antiviral compounds
08/01/2012EP2480551A1 Gpr 119 modulators
08/01/2012EP2480549A1 Fused imidazo [3, 2 - d]pyrazines as pi3 kinase inhibitors
08/01/2012EP2480548A2 Indolizine inhibitors of 5-lipoxygenase
08/01/2012EP2480547A2 Indolizine inhibitors of 5-lipoxygenase
08/01/2012EP2480546A1 Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10a inhibitors
08/01/2012EP2480545A1 Fused triazole amines as p2x7 modulators
08/01/2012EP2480544A1 Compounds which selectively modulate the cb2 receptor
08/01/2012EP2480543A1 Piperidine and piperazine derivatives as smo antagonists
08/01/2012EP2480538A1 [1,4]-benzodiazepines as vasopressin v2 receptor antagonists
08/01/2012EP2480536A2 Toll-like receptor modulators and uses thereof
08/01/2012EP2480535A1 Polymorphs of sorafenib acid addition salts
08/01/2012EP2480533A1 Heterocyclic antiviral compounds
08/01/2012EP2480532A1 Piperidine derivatives and their use to treat obesity, diabetes, dyslipidemia and atherosclerosis
08/01/2012EP2480531A1 Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators
08/01/2012EP2480530A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
08/01/2012EP2480529A1 Indole derivatives as crac modulators
08/01/2012EP2480528A1 Lysine specific demethylase-1 inhibitors and their use
08/01/2012EP2480527A1 Sulfanylamide derivatives, uses thereof and compositions comprising them
08/01/2012EP2480526A1 Crystalline forms and processes for the preparation of pgi2 receptor agonists
08/01/2012EP2480287A2 Dry powder combination of tiotropium
08/01/2012EP2480248A1 Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
08/01/2012EP2480246A2 Composition and method for treatment of diabetes
08/01/2012EP2480243A1 Pharmaceutical compositions for treating dysregulated inflammatory diseases
08/01/2012EP2480238A1 Surface coatings for skin
08/01/2012EP2480237A1 Methods of treatment with a low molecular weight heparin composition
08/01/2012EP2480236A1 Compositions and methods for treating bacterial infections using ceftaroline
08/01/2012EP2480235A2 Novel iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (mif)-implicated diseases and conditions
08/01/2012EP2480234A2 Sustained release composition of ranolazine
08/01/2012EP2480233A1 Methods and pharmaceutical compositions for treating down syndrome
08/01/2012EP2480232A1 Disubstituted ]4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones
08/01/2012EP2480231A2 New benzathine salts of ace inhibitors, process for their preparation and their use for the treatment of cardiovascular diseases
08/01/2012EP2480230A2 Dr5 ligand drug conjugates
08/01/2012EP2480229A2 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins
08/01/2012EP2480228A1 Use of nicotinic acetylcholine receptor alpha 7 activators
08/01/2012EP2480227A1 Retinal neuroprotection by ion channel blockers regulated by the sur subunit
08/01/2012EP2480226A2 Composition comprising s-allyl-l-cysteine as active ingredient for preventing or treating gastrointestinal disorders
08/01/2012EP2480225A2 Dermal formulations of dp2 receptor antagonists
08/01/2012EP2480224A1 Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases
08/01/2012EP2480223A1 Hydroxytyrosol compounds
08/01/2012EP2480220A2 Treatment and prevention of hiv infection
08/01/2012EP2480214A1 Orally transformable tablets
08/01/2012EP2480212A1 Oral pharmaceutical composition comprising diclofenac
08/01/2012EP2480211A1 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract
08/01/2012EP2480210A2 Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
08/01/2012EP2480207A2 Micelle encapsulation of therapeutic agents
08/01/2012EP2480206A1 Dicyclanil-based aqueous suspension and non-aqueous solution pour-on and spray on formulations for the prevention and treatment of insect infestation in animal
08/01/2012EP2480204A2 Topical formulation for diabetic foot ulcers
08/01/2012EP2480203A2 Dry powder formulation of tiotropium carried in blister strip
08/01/2012EP2480202A2 Carrying of a combination containing tiotropium in a blister strip
08/01/2012EP2480197A2 Formulations comprising triptan compounds
08/01/2012EP2480090A1 Disinfecting agent comprising eugenol, terpineol and thymol
08/01/2012EP2480086A1 Novel dihydropyrimidin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors
08/01/2012EP2480085A1 Combination
08/01/2012EP2480084A1 Combination
08/01/2012EP2480081A1 Bridged heterocyclic compounds and methods of use
08/01/2012EP2480080A1 Pyrido[3,4-b]indoles and methods of use
08/01/2012EP2480079A1 Pyrido(3,4-b)indoles and methods of use
08/01/2012EP2480078A1 Pyrido[4,3-b]indoles and methods of use
08/01/2012EP2480077A1 Novel pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use
08/01/2012EP2480076A1 Imidothiazole kinase inhibitors
08/01/2012EP2480075A1 Compositions and methods for inducing or enhancing connective tissue repair
08/01/2012EP2480074A1 Contact lens disinfecting solutions
08/01/2012EP2358714B1 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
08/01/2012EP2297166B1 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
08/01/2012EP2285817B1 Novel uses of d-mannopyranose derivatives activating angiogenesis
08/01/2012EP2265273B1 Hexahydrocyclopentyl[f] indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
08/01/2012EP2262770B1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
08/01/2012EP2252578B1 Conjugates for treating neurodegenerative diseases and disorders
08/01/2012EP2250176B1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
08/01/2012EP2245026B1 Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
08/01/2012EP2242757B1 Pyrazolopyridines as kinase inhibitors
08/01/2012EP2235013B1 Substituted tetrahydroimidazopyridine compounds and the use thereof in pharmaceuticals
08/01/2012EP2219625B1 Drug-containing nanoparticles comprising pioglitazone
08/01/2012EP2194128B1 Compositions and methods for inhibiting expression of the PCSK9 gene
08/01/2012EP2193793B1 Nerve cell death inhibitor
08/01/2012EP2173750B1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
08/01/2012EP2163554B1 Pyrimidodiazepinone derivative
08/01/2012EP2159224B1 Bromo-phenyl substituted thiazolyl dihydropyrimidines
08/01/2012EP2155201B1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
08/01/2012EP2149382B1 Dentinogenesis inducer and dentinogenesis pulp-capping material
08/01/2012EP2142552B1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
08/01/2012EP2131841B1 Methods for treating acute pain
08/01/2012EP2127646B1 Agent for relief or prevention of xerostomia
08/01/2012EP2121630B1 Fast dissociating dopamine 2 receptor antagonists
08/01/2012EP2119700B1 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
08/01/2012EP2097385B1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
08/01/2012EP2043625B1 Nfkappab inhibitors to treat pain locally
08/01/2012EP2034970B1 Sustained release pharmaceutical formulation comprising phenylephrine
08/01/2012EP2032535B1 Spirocyclic nitriles as protease inhibitors
08/01/2012EP2024363B1 N-oxides of pyridylmethylpiperazine and -piperidine derivatives
08/01/2012EP2024347B1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
08/01/2012EP2016039B1 Terphenyl derivatives for treatment of alzheimer' s disease
08/01/2012EP1994004B1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
08/01/2012EP1986625B1 Treatment of ovarian cancer
1 ... 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 ... 7860